BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 66 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,748 | +255.0% | 3,825 | +110.7% | 0.00% | – |
| Q1 2022 | $5,000 | -50.0% | 1,815 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -81.5% | 1,815 | -71.9% | 0.00% | – |
| Q3 2021 | $54,000 | +100.0% | 6,468 | +194.1% | 0.00% | – |
| Q2 2021 | $27,000 | -62.5% | 2,199 | -26.3% | 0.00% | – |
| Q1 2021 | $72,000 | -11.1% | 2,985 | +17.6% | 0.00% | – |
| Q4 2020 | $81,000 | +5.2% | 2,539 | 0.0% | 0.00% | – |
| Q3 2020 | $77,000 | -23.0% | 2,539 | +7.0% | 0.00% | – |
| Q2 2020 | $100,000 | +122.2% | 2,374 | +27.0% | 0.00% | – |
| Q1 2020 | $45,000 | – | 1,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $5,581,000 | 0.29% |
| NEA Management Company, LLC | 3,449,845 | $9,556,000 | 0.28% |
| Hawkeye Capital Management, LLC | 243,009 | $673,000 | 0.26% |
| DAFNA Capital Management LLC | 313,600 | $869,000 | 0.23% |
| Artal Group S.A. | 1,646,517 | $4,561,000 | 0.19% |
| MPM BioImpact LLC | 239,888 | $664,000 | 0.18% |
| RA Capital Management | 2,589,904 | $7,174,000 | 0.16% |
| Bellevue Group AG | 3,293,000 | $9,122,000 | 0.11% |
| Ikarian Capital, LLC | 159,390 | $441,000 | 0.06% |
| PDT Partners, LLC | 66,168 | $183,000 | 0.02% |